On 24 February, Repligen Corporation (NASDAQ:RGEN) announced that it has extended through 2019 a key long-term supply agreement with GE Healthcare for the manufacture of Protein A ligands at the Company’s facility in Lund, Sweden. In extending this agreement, the Company aligned important manufacturing and supply terms with its existing GE Healthcare long-term supply agreement, which runs through 2021, for production out of the Company’s Waltham, MA facility. The combined agreements maintain Repligen as the main strategic supplier of recombinant and native forms of Protein A ligands to GE Healthcare.
Repligen Corporation (NASDAQ:RGEN) belongs to Healthcare sector. Its net profit margin is 11.10% and weekly performance is 5.12%. On last trading day company shares ended up at $27.10. Repligen Corporation (NASDAQ:RGEN) distance from 50-day simple moving average (SMA50) is -6.83%.
Tumi Holdings, Inc. (NYSE:TUMI) and Samsonite International S.A. announced that they have entered into a definitive agreement whereby Samsonite will acquire Tumi for US$26.75 per share in an all cash transaction, valuing Tumi at an equity value of US$1.8 billion.
Tumi Holdings, Inc. (NYSE:TUMI) shares moved up 30.15% in last trading session and ended the day at $26.20. TUMI Gross Margin is 59.70% and its return on assets is 10.70%. Tumi Holdings, Inc. (NYSE:TUMI) quarterly performance is 51.80%.
EPR Properties (NYSE:EPR) announced that the Company’s President and CEO, Gregory Silvers, appeared as a featured guest on “Bloomberg ‹GO›” on Wednesday, March 2, 2016. Click here to view the appearance.
On 03 March, EPR Properties (NYSE:EPR) shares decreased -2.32% and was closed at $61.98. EPR EPS growth in last 5 year was 8.50%. EPR Properties (NYSE:EPR) year to date (YTD) performance is 7.17%.
On 25 February, Celldex Therapeutics, Inc. (NASDAQ:CLDX) reported business and financial highlights for the fourth quarter and year ended December 31, 2015. Cash, cash equivalents and marketable securities as of December 31, 2015 were $289.9 million compared to $304.6 million as of September 30, 2015.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares moved down -0.72% in last trading session and ended the day at $8.25. CLDX return on assets is -34.40%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is -53.70%.
HomeStreet, Inc. (NASDAQ:HMST) announced the completion of its previously announced charter conversion from a Washington state-chartered savings bank to a Washington state-chartered commercial bank.
HomeStreet, Inc. (NASDAQ:HMST) shares moved up 0.45% in last trading session and ended the day at $20.14. HMST return on assets is 0.90%. HomeStreet, Inc. (NASDAQ:HMST) quarterly performance is -9.73%.